Clinical Trial Details
EORTC-62961
Back to Clinical Trials Database
Randomized study comparing neoadjuvant chemotherapy Etoposide + Ifosfamide + Adriamycin (EIA) combined with regional hyperthermia (RHT) Vs neoadjuvant chemotherapy alone in the treatment of high-risk soft tissue sarcomas in adults. An Intergroup study with the European Society for hyperthermic oncology.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 11-Jul-1997 Date Step1 close: 20-Mar-2007 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 200 - All Groups: 340 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00003052 |
| NCT number | NCT00003052 |
